Global vaccine alliance Gavi is seeking new funding to provide vaccines for children in the world's poorest countries, Reuters reported on Thursday.
The organisation is reportedly seeking up to USD11.9bn from governments and foundations over the next five years.
The amount was expected to be finalised at a meeting on Thursday in Paris, France, with donors making pledges for the organisation's plan for 2026-2030.
Merck's CAPVAXIVE shows promising immune responses in adults at risk of pneumococcal disease
GSK PLC announces acceptance of NDA for gepotidacin by US FDA
Sanofi in talks to sell Opella stake
Orlance receives research grant to develop Enhanced Seasonal Influenza Vaccine
Anixa Biosciences plans Phase 2 breast cancer vaccine study
MedImmune's FluMist nasal spray influenza vaccine receives US FDA approval
Gavi signs agreement with Bavarian Nordic for Mpox vaccines
Valneva seeks label extensions for chikungunya vaccine in Europe and Canada
MinervaX and Wacker Biotech collaborate on GBS vaccine manufacturing
Merck's GARDASIL 9 shows promise in preventing HPV infection in Japanese males
OSE Immunotherapeutics initiates Phase 3 trial for cancer vaccine Tedopi
Pfizer names new Regional President for Middle East, Russia and Africa
LakeShore Biopharma names new chief executive officer
Valneva and Pfizer report positive Phase 2 booster results for Lyme disease vaccine